Waud Capital Partners Mergers and Acquisitions Summary

Private Equity Firm Profile

In the last 3 years, Waud Capital Partners has acquired 7 companies. It has also invested in 1 other.

Waud Capital Partners’ most common sectors for investment arehealthcare services (25%) and information technology (11%) . The Firm’s most common investment types include buyout (lbo, mbo, mbi) (55%) and growth capital (15%). In total, Waud Capital Partners has invested in 20 US states and 2 different countries.

In the last 3 years, Waud Capital Partners has exited 7 companies. The Firm’s most common exit type is trade sale (38%). Waud Capital Partners’ largest (disclosed) exit occurred in 2004 when it sold Sovereign Specialty Chemicals for $575M.

Join Mergr to view Waud Capital Partners’ full profile and discover more large private equity firm investors just like it.

M&A Summary

  • M&A Total Activity75
    • M&A Buy Activity48
    • M&A Sell Activity27
  • Total Sectors Invested 18
  • Total Countries Invested 2
  • M&A Buy/Sell Connections 30
  • M&A Advisors 11

Waud Capital Partners

Waud Capital Partners LLC

300 North LaSalle Street, Suite 4900,
Chicago, Illinois 60654
United States
(312) 676-8400
www.waudcapital.com
info@waudcapital.com

Waud Capital Partners is a private equity firm that pursues investments in mid-sized manufacturing, distribution and service companies. Waud looks for businesses with proven management, operating in well defined markets, and that demonstrate strong growth potential. The Firm typically invests $75 to $200 million. Specific areas of interest include adhesives, air/water treatment, alarm monitoring, auto components, coatings, consumer products, home healthcare services, hospitals, lighting, litigation support, medical distribution, petroleum distribution, pharmaceuticals, publishing, sealants, specialty hospitals, and tax consultants. Prospective transaction situations include buyouts, recapitalizations and industry consolidations. Waud Capital Partners was established in 1993 and is based in Chicago, Illinois.


Investment Criteria

Sectors of Interest: Business Services, Chemicals, Consumer Products, Consumer Services, Distribution, Electrical Equipment, Healthcare Services, Life Science, Machinery, Manufacturing, Medical Products, Publishing, Safety/Security

Target Transaction Types: Buyout (LBO, MBO, MBI), Consolidation, Divestiture, Growth Capital, Recapitalization

Geographic Preferences: East US, Midwest US, South US, West US, Canada

Transaction Criteria Min Max
Target Revenue - -
Target EBITDA - -
Investment Size 75 200
Enterprise Value - -
values in millions of USD

M&A Summary

Buy vs Sell

Year ≤ '19 '20 '21 '22 '23 '24 T
Buy (2.0/yr) # 38 2 3 1 2 2 48
Sell (1.6/yr) # 19 1 2 1 2 2 27
vol $1.0B $1.0B
  75

Most Recent M&A

Company Date Value Type
Science Exchange, Inc. 2024-09-30 - Buyout (LBO, MBO, MBI)
San Francisco, California · www.scienceexchange.com
SH Franchising LLC 2024-03-21 - Divestiture
Towson, Maryland · www.seniorhelpers.com
PSI Services LLC 2024-01-26 - Trade Sale
Olathe, Kansas · www.psiexams.com
Heart + Paw 2024-01-03 - Secondary Sale
Berwyn, Pennsylvania · www.heartandpaw.com
Integrated Practice Solutions 2023-09-21 - Merger
San Diego, California · www.chirotouch.com
PharmAlliance Holdings LP 2023-09-14 - Consolidation
Morrisville, North Carolina · www.pharmallianceportfolio.com
Cordant Health Solutions 2023-04-10 - Secondary Sale
Denver, Colorado · www.cordantsolutions.com
Fusion Health Dallas 2023-03-23 - Consolidation
Dallas, Texas
Zarya Intermediate LLC 2022-10-04 - Consolidation
Atlanta, Georgia · www.eptura.com
GI Alliance 2022-09-15 - Secondary Sale
Dallas, Texas · www.gialliance.com
View All >>

Portfolio M&A

Company Acquired Add-On/Sale Date #
SphereCommerce LLC 2017-08-01 Sphere Commercial Division 2023-10-12 1
Melville, New York · www.spherecommerce.com Nashville, Tennessee
PharmAlliance Holdings LP 2023-09-14 BioBridges LLC 2023-10-10 2
Morrisville, North Carolina · www.pharmallianceportfolio.com Morrisville, North Carolina · www.biobridges.com
Zarya Intermediate LLC 2022-10-04 Condeco Group Ltd. 2022-10-04 3
Atlanta, Georgia · www.eptura.com London, United Kingdom · www.condecosoftware.com
Zarya Intermediate LLC 2022-10-04 iOFFICE LLC 2022-10-04 2
Atlanta, Georgia · www.eptura.com Houston, Texas · www.iofficecorp.com
Zarya Intermediate LLC 2022-10-04 ARCHIBUS, Inc. 2022-10-04 1
Atlanta, Georgia · www.eptura.com Boston, Massachusetts · www.archibus.com
Ivy Rehab Network 2016-05-05 Theraplay, Inc. 2022-07-26 2
White Plains, New York · www.ivyrehab.com West Chester, Pennsylvania · www.theraplayinc.com

M&A by Sector

Sector Current # Value All-time # Value
Healthcare Services 5 (28%) - 12 (25%) -
Information Technology 2 (11%) - 5 (10%) -
Internet Software and Services 3 (17%) - 5 (10%) -
Business Services - - 4 (8%) -
Consumer Services 1 (6%) - 3 (6%) -
Life Science 1 (6%) - 3 (6%) -
Software 2 (11%) - 3 (6%) -
Education 2 (11%) - 2 (4%) -
Medical Products - - 2 (4%) -
Chemicals - - 1 (2%) -
Consumer Products - - 1 (2%) -
Distribution - - 1 (2%) -
Electrical Equipment - - 1 (2%) -
Franchising 1 (6%) - 1 (2%) -
Publishing - - 1 (2%) -
Safety/Security - - 1 (2%) -
Staffing 1 (6%) - 1 (2%) -
Transportation - - 1 (2%) -
Total 18 - 48 -

Acquisitions By Geo

State/Country Current # Value All-time # Value
United States 18 (100%) - 47 (98%) -
  Texas 4 (22%) - 7 (15%) -
  Illinois 1 (6%) - 7 (15%) -
  California 2 (11%) - 4 (8%) -
  New York 3 (17%) - 3 (6%) -
  Colorado 1 (6%) - 3 (6%) -
  Maryland 1 (6%) - 3 (6%) -
  Georgia 1 (6%) - 3 (6%) -
  Washington - - 2 (4%) -
  Tennessee - - 2 (4%) -
  Pennsylvania - - 2 (4%) -
  Michigan - - 2 (4%) -
  Florida 1 (6%) - 1 (2%) -
  North Carolina 1 (6%) - 1 (2%) -
  New Jersey 1 (6%) - 1 (2%) -
  Massachusetts 1 (6%) - 1 (2%) -
  Indiana 1 (6%) - 1 (2%) -
  Connecticut - - 1 (2%) -
  Virginia - - 1 (2%) -
  Ohio - - 1 (2%) -
  Kansas - - 1 (2%) -
Ireland - - 1 (2%) -
Domestic 18 (100%) - 47 (98%) -
Cross-border - - 1 (2%) -
Total 18 - 48 -

Acquisitions by Deal Type

Type Current # Value All-time # Value
Buyout (LBO, MBO, MBI) 5 (28%) - 26 (54%) -
Growth Capital 4 (22%) - 7 (15%) -
Consolidation 4 (22%) - 6 (13%) -
Secondary Buyout 2 (11%) - 4 (8%) -
Recapitalization 1 (6%) - 2 (4%) -
Divestiture 1 (6%) - 1 (2%) -
Stake Purchase 1 (6%) - 1 (2%) -
Venture - - 1 (2%) -
Total 18 - 48 -

Exits by Deal Type

Type Total # Value
Trade Sale 10 (37%) 575M (57%)
Secondary Sale 9 (33%) -
Trade Sale - Public Company 2 (7%) 433M (43%)
IPO 2 (7%) -
Unknown 2 (7%) -
Merger 1 (4%) -
Sold to Management 1 (4%) -
Total 27 $1.0B

Top M&A Advisors

Financial Deals
Raymond James - Investment Banking
 2
Software Equity Group
 1
Houlihan Lokey
 1
Legal Deals
Kirkland & Ellis
 7
McDermott Will & Emery
 1
Katten Muchin Rosenman
 1

Deal Values

sell # Total
$100M to $1B 3 $1.0B
TOTAL $1.0B
Largest Sovereign Specialty Chemicals, Inc.
$575M (2004-12-27)

M&A Connections

Deals
Acquired from
Investor(s)
8%
4 (8%)
Strategic(s)
2%
1 (2%)
Exited to
Investor(s)
33%
9 (33%)
Strategic(s)
37%
10 (37%)

Investor Summary

Investor Type

Private Equity Firm

Size

Large

PE Assets

3.2B USD

Established

1993

Specialist/Generalist

Generalist

Leadership

Reeve Waud

Founder & Managing Partner

Matthew Clary

Partner

Phillip Olson

Partner - Business Development

Christopher Graber

Partner - Healthcare Services

Justin DuPere

Partner - Software & Technology

FAQ

When was Waud Capital Partners founded?

Waud Capital Partners was founded in 1993.

What type of investor is Waud Capital Partners?

Waud Capital Partners is a private equity firm.

Where is Waud Capital Partners headquartered?

Waud Capital Partners is headquartered in Chicago, Illinois.

How much capital does Waud Capital Partners have under management?

Waud Capital Partners has 3.2B USD under management.

 Subscribe to unlock this and 209,130
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More
1 Week Free Trial Learn More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB

Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 202K M&A Transactions
  • 205K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.

Mergr

Product

Company

Legal